The Preston Robert Tisch Brain Tumor Center at Duke

John H. Sampson, MD, PhD

John H. Sampson, MD, PhD
Associate Professor of Surgery
Assistant Professor of Pathology
Associate Deputy Director, The Preston Robert Tisch Brain Tumor Center at Duke

Duke University Medical Center
DUMC Box 3050
Durham, NC 27710
Phone: (919) 684-9041
FAX: (919) 684-9045
email: john.sampson@duke.edu

Dr. Sampson completed his medical school in Canada and was then recruited to the Duke University Neurosurgery Residency Program. After completing the residency program, he was asked to stay on as a senior staff member in the Division of Neurosurgery. He also works in the neurosurgical portion of the Neuro-Oncology Program at the Duke Comprehensive Cancer Center.

Dr. Sampson has received special training in the surgical resection of very complex brain tumors. In addition, he has special training in the design and conduct of clinical trials. He did his research training under the internationally renowned scientist, Darell D. Bigner, and Nobel Laureate, Gertrude Elion. He currently focuses his clinical practice on treating patients with both benign and malignant brain tumors and divides his time between his clinical practice and an active research laboratory investigating new modalities of direct brain tumor infusion and immunotherapy.

Dr. Sampson is internationally recognized in the field of neurosurgery and has received a number of national and international awards and grants in recognition of his expertise in neuro-oncology and especially in the area of immunotherapy for brain tumors. Overall, he prides himself on being available to patients and their families and providing them with courteous and conscientious care. For more information, go to http://www.duke.edu/~sampson.

Recemt Publications:

Sampson JH,Archer GE,Mitchell DA,Heimberger AB,Bigner DD. Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.,Jun 06,2008, (-) - Seminars in immunology Abstract [More ...]

Vega EA,Graner MW,Sampson JH. Combating immunosuppression in glioma.,Jun 01,2008, (433-42) - Future oncology (London, England) Abstract [More ...]

Mitchell DA,Karikari I,Cui X,Xie W,Schmittling R,Sampson JH. Selective Modification of Antigen-Specific T Cells by RNA Electroporation.,May 09,2008, (-) - Human gene therapy Abstract [More ...]

Everson RG,Graner MW,Gromeier M,Vredenburgh JJ,Desjardins A,Reardon DA,Friedman HS,Friedman AH,Bigner DD,Sampson JH. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.,May 01,2008, (717-32) - Expert review of anticancer therapy Abstract [More ...]

Sampson JH,Akabani G,Archer GE,Berger MS,Coleman RE,Friedman AH,Friedman HS,Greer K,Herndon Ii JE,Kunwar S,McLendon RE,Paolino A,Petry NA,Provenzale JM,Reardon DA,Wong TZ,Zalutsky MR,Pastan I,Bigner DD. Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.,Apr 10,2008, (-) - Neuro-oncology Abstract [More ...]

Choi JD,Powers CJ,Vredenburgh JJ,Friedman AH,Sampson JH. Cryptococcal meningitis in patients with glioma: a report of two cases.,Apr 09,2008, (-) - Journal of neuro-oncology Abstract [More ...]

Mitchell DA,Fecci PE,Sampson JH. Immunotherapy of malignant brain tumors.,Apr 01,2008, (70-100) - Immunological reviews Abstract [More ...]

Grossi PM,Ellis MJ,Cummings TJ,Gray LL,Fukushima T,Sampson JH. Cholesterol granuloma of the lateral ventricle.,Feb 01,2008, (357-60) - Journal of neurosurgery Abstract [More ...]

Heimberger AB,Sun W,Hussain SF,Dey M,Crutcher L,Aldape K,Gilbert M,Hassenbusch SJ,Sawaya R,Schmittling B,Archer GE,Mitchell DA,Bigner DD,Sampson JH. Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study.,Dec 13,2007, (-) - Neuro-oncology Abstract [More ...]

Vogelbaum MA,Sampson JH,Kunwar S,Chang SM,Shaffrey M,Asher AL,Lang FF,Croteau D,Parker K,Grahn AY,Sherman JW,Husain SR,Puri RK. Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results.,Nov 01,2007, (1031-7; discussioin 1037-8) - Neurosurgery Abstract [More ...]

NOTE: For more publications on this researcher, please visit Pubmed - A service of the National Library of Medicine and the National Institutes of Health.

Leadership/Faculty/Staff